Patent · US Active

Antagonists of prostaglandin EP3 receptor

US9738626B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2015
Grant dateAug 22, 2017
Priority date—
Expiry dateDec 16, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.